(in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $7822 | $8497 | $9585 | $7935 |
Short term investments | $925 | $1046 | $872 | $914 |
Net receivables | $22557 | $24003 | $23476 | $22990 |
Inventory | $5645 | $4416 | $4514 | $4211 |
Total current assets | $37351 | $34518 | $34711 | $32027 |
Long term investments | $17985 | $18974 | $18967 | $19010 |
Property, plant & equipment | $3695 | $3924 | $3884 | $3837 |
Goodwill & intangible assets | $75122 | $77134 | $77524 | $77913 |
Total noncurrent assets | $115410 | $115127 | $115343 | $115949 |
Total investments | $18910 | $20020 | $19839 | $19924 |
Total assets | $152761 | $149645 | $150054 | $147976 |
Current liabilities | ||||
Accounts payable | $28368 | $26993 | $26689 | $24969 |
Deferred revenue | ||||
Short long term debt | $2775 | $3046 | $4618 | $3418 |
Total current liabilities | $48716 | $47059 | $47345 | $44727 |
Long term debt | $28155 | $28094 | $28115 | $29124 |
Total noncurrent liabilities | $57694 | $56820 | $57183 | $58653 |
Total debt | $30930 | $31140 | $32733 | $32542 |
Total liabilities | $106410 | $103879 | $104528 | $103380 |
Shareholders' equity | ||||
Retained earnings | $41652 | $40982 | $39936 | $38841 |
Other shareholder equity | -$1864 | -$2119 | -$1878 | -$1769 |
Total shareholder equity | $46223 | $45691 | $45445 | $44502 |
(in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $7822 | $5924 | $5081 | $10182 |
Short term investments | $925 | $905 | $920 | $1331 |
Net receivables | $22557 | $21961 | $20041 | $17391 |
Inventory | $5645 | $4777 | $3722 | $3165 |
Total current assets | $37351 | $30120 | $36134 | $27799 |
Long term investments | $17985 | $16288 | $18438 | $23262 |
Property, plant & equipment | $3695 | $4149 | $3692 | $4205 |
Goodwill & intangible assets | $75122 | $78303 | $79913 | $79827 |
Total noncurrent assets | $115410 | $113812 | $118755 | $127652 |
Total investments | $18910 | $17193 | $19358 | $24593 |
Total assets | $152761 | $143932 | $154889 | $155451 |
Current liabilities | ||||
Accounts payable | $28368 | $7775 | $21964 | $18825 |
Deferred revenue | ||||
Short long term debt | $2775 | $2993 | $2545 | $3374 |
Total current liabilities | $48716 | $36190 | $43572 | $36022 |
Long term debt | $28155 | $28100 | $31125 | $29545 |
Total noncurrent liabilities | $57694 | $57752 | $64133 | $69043 |
Total debt | $30930 | $31093 | $33670 | $32919 |
Total liabilities | $106410 | $99060 | $107705 | $105065 |
Shareholders' equity | ||||
Retained earnings | $41652 | $37874 | $32593 | $28575 |
Other shareholder equity | -$1864 | -$1075 | -$884 | -$861 |
Total shareholder equity | $46223 | $44872 | $47112 | $50321 |
(in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $49048 | $48586 | $46517 | |
Cost of revenue | $42566 | $42476 | $40505 | |
Gross Profit | $6482 | $6110 | $6012 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $3788 | $3434 | $3538 | |
Total operating expenses | $4242 | $3889 | $3997 | |
Operating income | $2240 | $2221 | $2015 | |
Income from continuing operations | ||||
EBIT | $2164 | $2197 | $1920 | |
Income tax expense | $391 | $374 | $295 | |
Interest expense | $365 | $363 | $358 | |
Net income | ||||
Net income | $1408 | $1460 | $1267 | |
Income (for common shares) | $1408 | $1460 | $1267 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $195265 | $180516 | $160401 | |
Cost of revenue | $170088 | $157040 | $136194 | |
Gross Profit | $25177 | $23476 | $24207 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $14822 | $13186 | $14072 | |
Total operating expenses | $16641 | $13400 | $16054 | |
Operating income | $8536 | $10076 | $8153 | |
Income from continuing operations | ||||
EBIT | $6751 | $9503 | $12275 | |
Income tax expense | $141 | $1607 | $2379 | |
Interest expense | $1446 | $1228 | $1438 | |
Net income | ||||
Net income | $5164 | $6668 | $8458 | |
Income (for common shares) | $5164 | $6668 | $8458 |
(in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
---|---|---|---|---|
Net income | $1029 | $1408 | $1460 | $1267 |
Operating activities | ||||
Depreciation | $765 | $766 | $755 | $749 |
Business acquisitions & disposals | -$4 | -$457 | $5 | $22 |
Stock-based compensation | ||||
Total cash flows from operations | $1467 | $2826 | $2492 | $5028 |
Investing activities | ||||
Capital expenditures | -$365 | -$403 | -$397 | -$408 |
Investments | $144 | -$439 | $14 | -$2554 |
Total cash flows from investing | -$440 | -$1337 | -$414 | -$2983 |
Financing activities | ||||
Dividends paid | -$358 | -$362 | -$362 | -$368 |
Sale and purchase of stock | -$470 | -$570 | -$125 | -$932 |
Net borrowings | -$286 | -$1586 | $192 | $1402 |
Total cash flows from financing | -$1250 | -$2572 | -$435 | -$37 |
Effect of exchange rate | $14 | -$7 | $4 | $5 |
Change in cash and equivalents | -$209 | -$1090 | $1647 | $2013 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $5164 | $6668 | $5365 | $8458 |
Operating activities | ||||
Depreciation | $3035 | $2937 | $2923 | $2802 |
Business acquisitions & disposals | -$434 | $4835 | -$1894 | $5453 |
Stock-based compensation | ||||
Total cash flows from operations | $11813 | $8656 | $7191 | $10350 |
Investing activities | ||||
Capital expenditures | -$1573 | -$1295 | -$1154 | -$1094 |
Investments | -$2835 | -$272 | -$660 | -$1406 |
Total cash flows from investing | -$5174 | $3098 | -$3611 | $2976 |
Financing activities | ||||
Dividends paid | -$1450 | -$1384 | -$1341 | |
Sale and purchase of stock | -$2097 | -$7218 | -$7416 | -$3666 |
Net borrowings | -$278 | -$2559 | $521 | -$4736 |
Total cash flows from financing | -$4294 | -$11240 | -$8212 | -$8533 |
Effect of exchange rate | $16 | -$86 | -$65 | $41 |
Change in cash and equivalents | $2361 | $428 | -$4697 | $4834 |
Why Cigna (CI) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance
27 Mar 2024
|
Morgan Stanley holds CIGNA stock at $392 target, cites growth potential
Investing.com
4 Mar 2024
|
Centene (CNC), Pyx Health Unite to Treat Mental Health Issues
Zacks via Yahoo Finance
1 Mar 2024
|
If You Invested $1000 in Cigna a Decade Ago, This is How Much It'd Be Worth Now
Zacks via Yahoo Finance
1 Mar 2024
|
Humana's board wants to remove barrier to sale or merger
WDRB 41 Louisville News
29 Feb 2024
|
The Most Profitable Company in Every State
GOBankingRates via Yahoo Finance
29 Feb 2024
|
Why Cigna (CI) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance
29 Feb 2024
|
3 HMO Stocks in Focus Despite High Tech Costs & Nursing Shortage
Zacks via Yahoo Finance
12 Feb 2024
|
16 Most Advanced Countries in Medicine
Insider Monkey via Yahoo Finance
12 Feb 2024
|
Stocks Win and Credit Loses as Companies Cater to Shareholders
Bloomberg via Yahoo Finance
9 Feb 2024
|
Market cap | $106.28B |
---|---|
Enterprise value | $129.39B |
Shares outstanding | 292.50M |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | 2.21 |
Book/Share | 164.40 |
Cash/Share | 26.74 |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | 2.30 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | 0.77 |
Quick ratio | 0.65 |